IBDEI1FL ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23897,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,23897,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,23898,0)
 ;;=E03.9^^116^1170^33
 ;;^UTILITY(U,$J,358.3,23898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23898,1,3,0)
 ;;=3^Hypothyroidism, unspec
 ;;^UTILITY(U,$J,358.3,23898,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,23898,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,23899,0)
 ;;=E16.2^^116^1170^30
 ;;^UTILITY(U,$J,358.3,23899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23899,1,3,0)
 ;;=3^Hypoglycemia, unspec
 ;;^UTILITY(U,$J,358.3,23899,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,23899,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,23900,0)
 ;;=E78.0^^116^1170^23
 ;;^UTILITY(U,$J,358.3,23900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23900,1,3,0)
 ;;=3^Hypercholesterolemia,Pure
 ;;^UTILITY(U,$J,358.3,23900,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,23900,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,23901,0)
 ;;=E78.0^^116^1170^28
 ;;^UTILITY(U,$J,358.3,23901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23901,1,3,0)
 ;;=3^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,23901,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,23901,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,23902,0)
 ;;=E78.5^^116^1170^25
 ;;^UTILITY(U,$J,358.3,23902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23902,1,3,0)
 ;;=3^Hyperlipidemia, unspec
 ;;^UTILITY(U,$J,358.3,23902,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,23902,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,23903,0)
 ;;=E87.1^^116^1170^29
 ;;^UTILITY(U,$J,358.3,23903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23903,1,3,0)
 ;;=3^Hypo-osmolality and hyponatremia
 ;;^UTILITY(U,$J,358.3,23903,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,23903,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,23904,0)
 ;;=E87.5^^116^1170^24
 ;;^UTILITY(U,$J,358.3,23904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23904,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,23904,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,23904,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,23905,0)
 ;;=E87.6^^116^1170^31
 ;;^UTILITY(U,$J,358.3,23905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23905,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,23905,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,23905,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,23906,0)
 ;;=G81.91^^116^1170^11
 ;;^UTILITY(U,$J,358.3,23906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23906,1,3,0)
 ;;=3^Hemiplegia affecting rt dominant side, unspec
 ;;^UTILITY(U,$J,358.3,23906,1,4,0)
 ;;=4^G81.91
 ;;^UTILITY(U,$J,358.3,23906,2)
 ;;=^5004121
 ;;^UTILITY(U,$J,358.3,23907,0)
 ;;=G81.92^^116^1170^9
 ;;^UTILITY(U,$J,358.3,23907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23907,1,3,0)
 ;;=3^Hemiplegia affecting lft dominant side, unspec
 ;;^UTILITY(U,$J,358.3,23907,1,4,0)
 ;;=4^G81.92
 ;;^UTILITY(U,$J,358.3,23907,2)
 ;;=^5004122
 ;;^UTILITY(U,$J,358.3,23908,0)
 ;;=G81.93^^116^1170^12
 ;;^UTILITY(U,$J,358.3,23908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23908,1,3,0)
 ;;=3^Hemiplegia affecting rt nondom side, unspec
 ;;^UTILITY(U,$J,358.3,23908,1,4,0)
 ;;=4^G81.93
 ;;^UTILITY(U,$J,358.3,23908,2)
 ;;=^5004123
 ;;^UTILITY(U,$J,358.3,23909,0)
 ;;=G81.94^^116^1170^10
 ;;^UTILITY(U,$J,358.3,23909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23909,1,3,0)
 ;;=3^Hemiplegia affecting lft nondom side, unspec
 ;;^UTILITY(U,$J,358.3,23909,1,4,0)
 ;;=4^G81.94
 ;;^UTILITY(U,$J,358.3,23909,2)
 ;;=^5004124
 ;;^UTILITY(U,$J,358.3,23910,0)
 ;;=H91.90^^116^1170^7
 ;;^UTILITY(U,$J,358.3,23910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23910,1,3,0)
 ;;=3^Hearing loss, unspec ear, unspec
 ;;^UTILITY(U,$J,358.3,23910,1,4,0)
 ;;=4^H91.90
